Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
About
About the Journal
Privacy Statement
Open access policy
Contact
Current
Archives
Editorial Board
Procedure for consideration and publication of materials
Guides for authors
Cost of publication
Archive 2018-2006
Search
Register
Login
Home
/
Archives
/
Vol. 44 No. 2 (2022): Experimental Oncology
Vol. 44 No. 2 (2022): Experimental Oncology
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2
Published:
26.05.2023
Editorial
SYMBIOSIS OF MEDICAL TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE: NEW OPPORTUNITIES IN ONCOLOGY
Vasyl Chekhun
90-92
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17951
Frontiers in oncology
OECI 2022 ONCOLOGY DAYS AND GENERAL ASSEMBLY
The OECI 2022 Oncology Days and the OECI General Assembly were held in Valencia (Spain) on June 15–17.
93-94
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17945
Reviews
HUMAN MICROBIOTA AND BREAST CANCER
Yu.V. Shvets, O.O. Lykhova, V.F. Chekhun
95-106
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17855
Original contributions
SIGNIFICANCE OF ADC MEASUREMENTS AS RADIOLOGICAL MRI MARKER IN DETECTION OF METASTATIC LYMPH NODE INVOLVEMENT IN PATIENTS WITH PROSTATE CANCER
Yu.O. Mytsyk, S.M. Pasichnyk, Yu.S. Kobilnyk, O.A. Borzhiievskyi, O.E. Lychkovskyy, P. Kowal, M. Pietrus, V.M. Matskevych, R.I. Dats, O.M. Blavatska, E.O. Stakhovsky, A.I. Gozhenko, A.Ts. Borzhiievskyi
142-147
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17810
CHEMORESISTANCE RELATED TO HYPOXIA ADAPTATION IN MESOTHELIOMA CELLS FROM TUMOR SPHEROIDS
D. Endoh, K. Ishii, K. Kohno, N. Virgona, Y. Miyakoshi, T. Yano, T. Ishida
121-125
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.18045
TRANSCRIPTIONAL ANALYSIS OF ZINC-DEPENDENT HISTONE DEACETYLASES IN SEVERAL HUMAN CANCER CELLS
Yan Li, Yefang Zou, Xiaoxue Chen, Bin He
126-131
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17983
EXPRESSION OF miRNA AS PROGNOSTIC MARKERS OF RENAL CELL CARCINOMA COURSE
Yu. Vitruk, T. Borikun, O. Rossylna, T. Zadvornyi, S. Semko, O. Voylenko, O. Stakhovsky, A. Shipko, E. Stakhovsky
132-136
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17883
POLYAMINES AS NEW POTENTIAL BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PROSTATE CANCER AND ESTIMATION OF ITS AGGRESSIVENESS
S.P. Zaletok, O.O. Klenov, V.V. Bentrad, M.P. Prylutskyi, Yu.V. Vitruk, E.O. Stakhovsky, A.V. Timoshenko
148-154
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17758
ONCOLYTIC ACTIVITY OF HUMAN ORTHOPNEUMOVIRUS IN CANCER CELL LINES
I.M. Aziz, R. Bhat, M.A. Farrag, F.N. Almajhdi
113-120
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.18084
EXPRESSION OF CHEMOKINE (C-C MOTIF) RECEPTOR 7 IN PROSTATE CANCER TISSUE OF YOUNG PATIENTS AND IN METASTATIC CANCER CELLS
R. Parra-Medina, C. Payán-Gómez, N.L. Acosta-Vega, S. Ramírez-Clavijo
137-141
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.18025
EXPRESSION OF OSTEOPONTIN AND OSTEONECTIN IN BREAST AND PROSTATE CANCER CELLS WITH DIFFERENT SENSITIVITY TO DOXORUBICIN
T. Zadvornyi, N. Lukianova, T. Borikun, S. Gogol, P. Virych, O. Lykhova, V. Chekhun
107-112
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17886
Short communications
АNTIMETASTATIC EFFECT OF B. SUBTILIS IMV B-7724 LECTIN OBSERVED IN LEWIS LUNG CARCINOMA MODEL
N.I. Fedosova, T.V. Symchych, N.L. Cheremshenko, A.V. Chumak, E.V. Koval, O.M. Karaman, I.M. Voyeykova
155-158
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17914
THE CHANGES OF NO LEVEL AND RNase ACTIVITY IN TUMOR TISSUE ACCOMPANYING THE PROGRESSION OF PROSTATE CANCER
А.P. Burlaka, S.V. Virko, V.M. Grygorenko, O.A. Samoylenko, A.V. Verbinenko, V.O. Shlyakhovenko
159-162
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17785
SERUM ANTIBODIES AGAINST GroEL AS AN ADDITIONAL RISK BIOMARKER OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMYSERUM ANTIBODIES AGAINST GroEL AS AN ADDITIONAL RISK BIOMARKER OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
V. Grygorenko, Ye. Afanasiev, R. Danylets, M. Vikarchuk, O. Shulyak
163-168
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17827
Case report
CLINICAL CASE OF NON-TYPICAL METASTASIS OF NEUROENDOCRINE LUNG CARCINOMA TO THE VASCULAR MEMBRANE OF THE EYE
L.M. Zakhartseva, H.E. Chytaieva, O.V. Artemov
169-173
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17969
PRIMARY CUTANEOUS ADENOID CYSTIC CARCINOMA IN THE TRUNK: CASE REPORT AND LITERATURE REVIEW
M. Moreno, A. de Oliveira, I. Czarnobai, T. Cássia Boff
174-176
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.18006
Language
Українська
English
Current Issue